We have previously shown that expression of active Rac1 and Cdc4Hs inhibits skeletal muscle cell dierentiation. We show here, by bromodeoxyuridine incorporation and cyclin D1 expression, that the expression of active Rac1 and Cdc42Hs but not RhoA impairs cell cycle exit of L6 myoblasts cultured in dierentiation medium. Furthermore, expression of activated forms of Rac1 and Cdc42Hs elicits the loss of cell contact inhibition and anchorage-dependent growth as measured by focus forming activity and growth in soft agar. RhoA was once again not found to have this eect. We found a constitutive Rac1 and Cdc42Hs activation in three human rhabdomyosarcoma-derived cell lines, one of the most common causes of solid tumours arising from muscle precursors during childhood. Finally, dominant negative forms of Rac1 and Cdc42Hs inhibit cell proliferation of the RD rhabdomyosarcoma cell line. These data suggest an important role for the small GTPases Rac1 and Cdc42Hs in the generation of skeletal muscle tumours.
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The dierentiation of skeletal muscle cells is a multistep process and coordinately involves withdrawal of myoblasts from the cell cycle, a prerequisite for dierentiation, and activation of muscle-speci®c gene expression and myoblasts fusion (Lassar et al., 1994) . The Rho family of Ras-like GTPases act as molecular switches in regulating a variety of biological response pathways (Van Aelst and D'Souza-Schorey, 1997) . In addition to their roles in cytoskeleton-dependent cell function, Rho GTPases also regulate gene transcription. In particular, RhoA, Rac1 and Cdc42Hs play important antagonistic roles during myogenesis. RhoA GTPase, via SRF activation, positively controls MyoD expression and skeletal muscle dierentiation (Carnac et al., 1998; Takano et al., 1998; Wei et al., 1998) . In contrast, Rac1 and Cdc42Hs negatively regulate myogenesis (Gallo et al., 1999; Meriane et al., 2000) . Recently, it was reported that Rac1 inhibits myogenesis by preventing the withdrawal of myoblasts from the cell cycle (Heller et al., 2001) . Having already shown that Rac1 and Cdc42Hs inhibit skeletal myogenesis (Meriane et al., 2000) , we wanted to know whether expression of these two GTPases aected also mitogenesis and proliferation of myoblasts.
By using the previously established L6 myoblast cell lines expressing constitutively active forms of Rac1, Cdc42Hs (G12V) and RhoA (G14V) (Meriane et al., 2000) , we decided to study myoblast proliferation. Time-course analysis of cells cultured in 10% serum (proliferation medium, PM) indicated that whereas L6 expressing an empty control vector and L6 RhoAV14 rapidly reached the saturation density plateau, L6 Rac1V12 and L6 Cdc42HsV12 grew at a higher saturation density (Figure 1a ). Similar analysis was performed in cells cultured in low (2%)-serum (dierentiation medium, DM). Figure 1b shows that L6 expressing an empty control vector and L6 RhoAV14 rapidly exited from the cell cycle. In contrast, expression of Rac1V12 or Cdc42HsV12 in L6 myoblasts impairs withdrawal from the cell cycle, therefore causing them to grow at higher saturation density. To further con®rm the absence of exit from the cell cycle of L6 Rac1V12 and L6 Cdc42HsV12, cells in S phase were identi®ed by bromodeoxyuridine (BrdU) incorporation after addition of DM ( Figure  2a ). Whereas 10% of parental L6 (not shown), L6 expressing an empty control vector and L6 RhoAV14 were in S phase after 48 h in DM, more than 50% of L6 Rac1V12 or L6 Cdc42HsV12-expressing cells incorporated the BrdU. Expression of cyclin D1, a marker of proliferation which decreases as myoblast withdrawal from the cell cycle (Rao and Kohtz, 1995) was also analysed (Figure 2b ). Cyclin D1 expression decreased in parental L6 and L6 RhoAV14 cultured in DM, whereas its expression was fully maintained in L6 Rac1V12 and L6 Cdc42HsV12 after 24 or 48 h in DM. In this experiment, a-tubulin was monitored as an internal loading control. These data demonstrate that expression of constitutively active forms of Rac1 and Cdc42Hs in L6 myoblasts impaired exit from the cell cycle and maintained myoblasts in the proliferative state. The antagonism between proliferation and dierentiation of skeletal muscle cells implies that signalling pathways driving proliferation must be suppressed to allow induction of dierentiation (Walsh and Perlman, 1997) . Moreover, expression of cyclin D1, which normally fell below detectable levels during myoblast dierentiation (Rao and Kohtz, 1995) , was maintained in Rac1-and Cdc42Hs-expressing myoblasts cultured in DM. These data are in agreement with a role for Rac1 in cell cycle progression (Joneson and Bar-Sagi, 1998; Olson et al., 1995) and cyclin D1 expression . Whereas Cdc42Hs has also been implicated in cell cycle progression (Olson et al., 1995) , we demonstrated here for the ®rst time that Cdc42Hs positively controls cyclin D1 expression in myoblasts. Further work is necessary to clarify the connection between Rac1 and Cdc42Hs signalling, cyclin D1 expression and proliferation.
As soon as L6 Rac1V12-expressing cells reached con¯uency, cell aggregates were clearly visible. Thus, we examined whether activated forms of Rac1 and Cdc42Hs might induce focus formation. Control L6, L6 RhoAV14, L6 Rac1V12 and L6 Cdc42HsV12 cell lines were seeded at high density and incubated in medium containing 2% foetal calf serum. Three days after seeding, numerous pile up cells were detectable in Rac1V12-and Cdc42HsV12-expressing L6 myoblasts ( Figure 3a ). L6 myoblasts expressing Cdc42HsV12 tended to round up and detach from the substratum, Figure 1 Changes in cell saturation density upon expression of Rac1 and Cdc42Hs but not RhoA. L6 myoblasts (Vandromme et al., 1992) expressing empty control vector or stable L6 myoblasts cell lines expressing activated forms of Rac1, Cdc42Hs and RhoA (Meriane et al., 2000) were seeded in 60 mm dishes at 50610 3 cells per dish and cultured in proliferation medium (PM) containing 10% foetal calf serum (FCS) (a) or in dierentiation medium (DM) containing 2% FCS (b). Daily counting of the number of cells after trypsinization was performed during 9 days. Growth kinetics obtained from four independent experiments are presented. s.e.m.s (all lower than 5% are not shown) Figure 2 Rac1 and Cdc42Hs but not RhoA prevented the withdrawal of L6 myoblasts from the cell cycle. (a) L6 myoblasts expressing empty control vector or stable L6 myoblasts cell lines expressing activated forms of Rac1, Cdc42Hs and RhoA were shifted to DM for 24 or 48 h. Bromodeoxyuridine (BrdU) was added to the medium at 10 mM for 2 h before cells were ®xed in 3.7% formaldehyde and stained for BrdU incorporation and for DNA with Hoechst dye as described (Gauthier-Rouviere et al., 1991) . The histogram represents the percentage of BrdU-positive cells of three independent sets of experiments; more than 100 cells were analysed in each experiment. (b) Cells were lyzed in Laemmli sample buer (40 mM Tris-HCl pH 6.8, 5 mM DTT, 1% SDS, 7.5% glycerol, 0.01% bromophenol blue). Protein extracts (50 mg/ well) were fractionated on a 12.5% SDS ± PAGE and transferred onto nitrocellulose. Membranes saturated in 5% milk in PBS were immunoblotted with an anti-cyclin D1 antibody (Tebu). Membranes were washed and incubated with peroxidase-conjugated anti-mouse antibody (1 : 2000 dilution, Amersham) and processed as described (Meriane et al., 2000) . Shown are Western blots indicating the expression of cyclin D1 and a-tubulin in L6 myoblasts expressing control vector or stable L6 myoblast cell lines expressing activated forms of Rac1V12, Cdc42HsV12 and RhoAV14 cultured in proliferating medium (P) or dierentiation medium for 24 (D1) or 48 (D2) h consistent with a previous study showing that Cdc42Hs regulates anchorage-independent growth (Qiu et al., 1997) . In contrast, cells expressing Rac1V12 led to pile up cells of dierent morphology, consisting of densely packed cells forming mountain-like foci. No pile up cells were detected in control L6 myoblasts transfected with an empty vector or in L6 RhoAV14. Pile up cells quanti®cation is shown on the graph Figure 3a . We next performed soft agar assay to assess whether expression of these Rho GTPases might aect anchorage-independent cell growth. Colony formation in soft agar in control L6 myoblasts or after expression of RhoAV14 was inecient. In contrast, L6 myoblasts expressing Rac1V12 or Cdc42HsV12 grew in soft agar as shown in Figure 3b . Quanti®cation of colony formation in soft agar is shown on the graph Figure  3b . These data show that expression of constitutively active Rac1 or Cdc42Hs is sucient to induce both growth of L6 myoblasts in low serum and anchorage independence, hallmarks of cell transformation. Both Figure 3 Focus formation and growth in soft agar induced by Rac1 and Cdc42Hs in L6 myoblasts. (a) L6 myoblasts expressing empty control vector or stable L6 myoblasts expressing constitutive active forms of Rac1, Cdc42Hs and RhoA were seeded at 10610 4 cells per 60 mm dishes. One day after, foetal calf serum was reduced to 2%. Three days after cells reached con¯uency, pile up cells were stained as described (Roux et al., 1997) . Phase contrast images of control L6, L6 RhoAV14 and pile up cells obtained with L6 Rac1V12 and L6 Cdc42HsV12 are shown. The quanti®cation (mean and s.e.m.s) of the pile up cells obtained from four independent experiments is shown. (b) Sixty mm dishes were coated with 4 ml per dish of 0.5% agarose in DMEM/HAM-F12 containing 10% FCS. L6 myoblasts expressing empty control vector or L6 myoblasts expressing constitutive active forms of Rac1, Cdc42Hs and RhoA were resuspended at 4610 5 cells in 5 ml DMEM/HAM-F12 supplemented with 10% FCS and warmed at 378C. One ml of prewarmed (428C) 0.3% agarose in DMEM/HAM-F12 containing 10% FCS was mixed with the cell suspension and then layered on to the pre-coated 60 mm dishes. The agar was allowed to solidify at room temperature for 25 min before adding 2 ml of growth medium. Every 2 days, 2 ml of growth medium was added. After 7 days, the colonies were counted and phase contrast images were acquired at the CRBM integrated imaging facility. Shown are phase contrast images of colonies obtained with L6 Rac1V12 and L6 Cdc42HsV12. The quanti®cation (mean and s.e.m.s) of the colonies obtained from four independent experiments is shown 2), 1% Triton X-100, 0.5% sodium deoxycholate, 500 mM NaCl, 10 mM MgCl 2 , 1 mM PMSF and cocktail protease inhibitor (Sigma). Cleared lysate were incubated with GST-Pak CRIB bound to glutathione-coupled Sepharose beads for 30 min at 48C. Beads were washed three times in 50 mM Tris-HCl (pH 7.2), 1% Triton X-100, 150 mM NaCl, 10 mM MgCl 2 . The bound proteins were eluted from beads by addition of Laemmli sample buer, resolved on 15% SDS ± PAGE and immunoblotted using anti-Rac1 and anti-Cdc42Hs antibodies (Transduction Laboratory) (upper lanes). The total amount of Rac1 and Cdc42Hs in the whole cell lysates was determined by Western blot (lower lanes). Rac1 and Cdc42Hs GTPases have been implicated in ®broblast cell transformation, with Cdc42Hs controling anchorage requirement and Rac1 activation leading to a reduction in contact inhibition (Qiu et al., 1997; Roux et al., 1997) . Rac1 and Cdc42Hs seem to similarly aect growth and transformation of myoblasts. Downstream mechanisms controlling proliferation and transformation remain to be determined. In particular, whether JNK activation, which inhibits myogenesis, might also participate in myoblasts growth and transformation will be interesting to know. JNK activation was indeed previously shown to contribute to Ras transformation . Expression of RhoA GTPase has no eect neither on myoblast proliferation nor on transformation. This is in contrast to data obtained in NIH3T3 cells in which expression of activated forms of RhoA induces transformation (Khosravi-Far et al., 1995; Qiu et al., 1995; Sahai et al., 2001) . In this respect, it is interesting to note that RhoA but not Rac1 and Cdc42Hs GTPases positively regulate myogenesis through MyoD (Carnac et al., 1998) suggesting that in the skeletal muscle cellular context RhoA has no eect on cell proliferation and transformation.
The preceding results suggested that Rac1 and Cdc42Hs might mediate transformation pathways in myoblastic cells. We thus investigated the activation status of Rac1 and Cdc42Hs in the three human rhabdomyosarcoma (RMS) cell lines (RD, A-204 and A-673) obtained from tumours of skeletal origin using a RBD (Rho Binding Domain)-pulldown assay ( Figure  4a ). Cells lysates were incubated with glutathione-Stransferase (GST) fused to the CRIB domain of the Rac/Cdc42Hs eector molecule Pak (GST-Pak CRIB) and activated, i.e. GTP-loaded Rac1 and Cdc42Hs bound to GST-Pak CRIB analysed by Western blot. A strong activation of endogenous Rac1 was detected in RMS cells compared with untreated L6 myoblasts. Similarly, a strong activation of Cdc42Hs was detected in RMS cells but not in untreated L6 myoblasts. The total levels of Rac1 and Cdc42Hs were similar in all conditions. Thus, Rac1 and Cdc42Hs appear to be constitutively activated in the RD, A-204 and A-673 human rhabdomyosarcoma cell lines. To further con®rm Rac1 and Cdc42Hs activation in these cell lines, we studied the organization of the actin cytoskeleton and the plasma membrane organization as a functional read-out. F-actin staining with rhodamine-labelled phalloidin was performed in control L6, L6 Rac1V12, L6 Cdc42HsV12, RD, A-204 and A-673 cells (Figure 4b ). Rac1 activation induces lamellipodia (panel b) (Ridley et al., 1992) and Cdc42Hs activation induces ®lopodia formation (panel c) (Kozma et al., 1995) . F-actin staining of RMS cells reveals the presence of both lamelipodia (arrow in panels d, e and f) and ®lopodial extensions (arrowheads in panels d, e and f) at the edges of the cell as well as a reduction in stress ®bres another speci®c aect of Rac1 and Cdc42Hs activities (compare panels d, e and f to panel a) (Gauthier et al., 1998; Kozma et al., 1995) . Plasma membrane organization was analysed using scanning electron microscopy ( Figure 4c) . Expression of Rac1 (panel b) and Cdc42Hs (panel c) induces lamellipodia and ®lopodia formation, respectively. Again typical Rac1 and Cdc42Hs cell surface morphology modi®cations were visible in RD (panel d), A-204 (panel e) and A-673 (panel f) cells. With these data we can conclude that RMS-derived cell lines display constitutive endogenous Rac1 and Cdc42Hs activities. In order to correlate constitutive Rac1 and Cdc42Hs activity in RD cells with proliferation, we have performed BrdU incorporation in RD cells expressing dominant negative forms of Rac1 (Rac1N17) and Cdc42Hs (Cdc42HsN17). As shown in Figure 4d , expression of Rac1N17 and Cdc42HsN17 decreased cell proliferation of RD cells as measured by BrdU incorporation 24 and 48 h after transfection. Quanti®cation of these results shows that BrdU incorporation was reduced from 24 to 4.4% and 2.65% 24 h after Rac1N17 and Cdc42HsN17 expression, respectively and from 22 to 4.8 and 3% 48 h after Rac1N17 and Cdc42HsN17 expression, respectively. This experiment was performed in RD cells which are the most transfectable RMS-derived cell lines. Attempts to reverse myogenesis inhibition by the expression of dominant negative forms of Rac1 and Cdc42Hs were unsuccessful, since expression of these mutants inhibits myogenesis on its own through the decrease in p38 activity which is essential for myogenesis (Cuenda and Cohen, 1999; Meriane et al., 2000; Wu et al., 2000; Zetser et al., 1999) . In addition, increase in p38 activity in some RMS cells, was shown to lead to growth arrest and terminal dierentiation . Dierent but not exclusive mechanisms might be proposed for the constitutive Rac1 and Cdc42Hs activity. First, point mutations in these GTPases might be responsible for their constitutive activation as previously observed for Ras (Mangues and Pellicer, 1992) . The deregulation of regulatory proteins such as GEFs or GAPs might also be envisaged. RBD-pulldown assay using GFP-tagged Rac1WT-and Cdc42HsWT-transfected myoblasts suggest that the regulation of the GDP/GTP state of these proteins was altered (data not shown). Along this forms of Rac1 (Rac1N17) or Cdc42Hs (Cdc42HsN17) were incubated with 10 mM bromodeoxyuridine (BrdU) for 2 h before ®xation 24 and 48 h after transfection. Cells were stained for BrdU incorporation and for DNA (Gauthier-Rouviere et al., 1991) . Values represent the percentage of BrdU positive GFP-expressing cells. The results shown are representative of two independent experiments. Two hundred cells were scored. s.e.m.s are less than 2%. (e) L6 myoblasts and human rhabdomyosarcoma (RMS) cells RD, A-204 and A-673 were processed as described in (a) using instead of GST-Pak CRIB, GST-RafGDSRBD. The bound and the total amount of Ras in the whole cell lysates was determined by Western blot using a monoclonal anti-Ras antibody (Oncogene, Calbiochem) line, N-ras gene mutation and activation has been described in the RD human rhabdomyosarcoma cell line (Chardin et al., 1985) . We have also measured the Ras activity status in RD, A-204 and A-673 cells with an anity precipitation assay using GST fused to the Ras binding domain of RalGDS (GST-RalGDSRBD) (Figure 4d ). The total level of Ras was similar in the dierent conditions while a strong activation of Ras is detected in RD, A-204 and A-673 cells. Constitutive Ras activation, therefore, might then keep activated the Rac1/Cdc42Hs downstream pathways without any eect on the RhoA pathway in this cell system (data not shown). Our data suggest that in skeletal muscle cells only Ras, Rac1 and Cdc42Hs but not RhoA participate in cell transformation. Thus dierent Rho GTPases-dependent mechanisms might be involved in cell transformation depending upon the cell type studied or the transforming protein acting upstream the Rho GTPases (revue in Zohn et al., 1998) . Similar Rac1 and Cdc42Hs activation downstream of Ras has been described in NIH3T3 and Rat1 cells which is consistent with the morphological modi®cations induced by Ras in these cells (Khosravi-Far et al., 1995) . In addition, RhoA might be inactivated downstream of Ras in Rac1 ®broblasts (Izawa et al., 1998) . In contrast, in Ras-transformed MCF10A breast epithelial cells, RhoA activation is a major event of the transformation process Zhong et al., 1997) as well as in Ras-transformed Swiss3T3 (Sahai et al., 2001) .
Whereas an increased amount of Rho GTPase has been described in epithelial human tumours (Fritz et al., 1999) , no such variation in the amount of neither Rac1 nor Cdc42Hs GTPases was detected in rhabdomyosarcoma cells versus normal myoblasts (data not shown). Interestingly, hyperactive Rac3 and persistent kinase activity of the Rac eector p21-activated kinase and also JNK have been detected in human breast cancer-derived cell lines (Mira et al., 2000) . Determination of the Rac1 and Cdc42Hs eectors participating in myoblasts transformation will be important not only for the understanding of the downstream mechanisms but also to envisage therapeutic strategies of RMS.
